These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3445592)

  • 21. [Prevention of the formation of a mutant influenza A virus resistant to rimantadine (alpha-methyl-1-adamantanemethylamine hydrochloride) by using ribavirin (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide)].
    Pushkarskaia NL; L'vov ND; Galegov GA
    Vopr Virusol; 1980; (3):303-6. PubMed ID: 7434722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza virus uncoating in infected cells and effect of rimantadine.
    Bukrinskaya AG; Vorkunova NK; Kornilayeva GV; Narmanbetova RA; Vorkunova GK
    J Gen Virol; 1982 May; 60(Pt 1):49-59. PubMed ID: 7097250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative evaluation of the therapeutic effectiveness of virazole and remantadine in patients with influenza caused by A(H3N2) and B viruses].
    Kolobukhina LV; Krylov VF; Grushinskaia IA; Ivanova LA; Poliakova TG
    Vopr Virusol; 1985; 30(3):296-8. PubMed ID: 4049841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tissue reaction and influenza virus infectiousness during multiplication in tissue culture in the presence of remantadine].
    Votiakov VI; Boreko EI; Zaporozhets LK
    Vopr Virusol; 1984; 29(4):468-73. PubMed ID: 6495707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rimantadine approved for treatment, prophylaxis of influenza A.
    Am J Hosp Pharm; 1994 Jan; 51(1):16. PubMed ID: 8135257
    [No Abstract]   [Full Text] [Related]  

  • 26. [Synthesis of virus-specific RNA in influenza virus-infected cells in the presence of bonafton].
    Gerasina SF; Farashian VR; Fadeeva NI; Pershin GN; Zhdanov VM
    Farmakol Toksikol; 1985; 48(4):92-5. PubMed ID: 2412888
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antiviral action of a polyphenol complex isolated from the medicinal plant Geranium sanguineum L. I. Its inhibiting action on the reproduction of the influenza virus].
    Manolova N; Gegova G; Serkedzhieva Iu; Maksimova-Todorova V; Uzunov S
    Acta Microbiol Bulg; 1986; 18():73-7. PubMed ID: 3776704
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antiviral action of fractions isolated from propolis].
    Maksimova-Todorova V; Manolova N; Gegova G; Serkedzhieva Iu; Uzunov S
    Acta Microbiol Bulg; 1985; 17():79-85. PubMed ID: 3834770
    [No Abstract]   [Full Text] [Related]  

  • 29. Amantadine may be lifesaving in severe influenza A.
    Cunha BA
    Clin Infect Dis; 2006 Nov; 43(10):1372-3. PubMed ID: 17051511
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of sodium selenite and its combination with remantadine on the synthesis of virus-specific polypeptides in a cell culture infected with influenza A virus].
    Abdullaev II; Asadullaev TB; Abdullaev FI
    Vopr Virusol; 1988; 33(6):676-80. PubMed ID: 3247686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antivirals--current trends in fighting influenza.
    Król E; Rychłowska M; Szewczyk B
    Acta Biochim Pol; 2014; 61(3):495-504. PubMed ID: 25180220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rimantadine for influenza A prevention and treatment.
    Nurse Pract; 1994 Sep; 19(9):22, 24. PubMed ID: 7816368
    [No Abstract]   [Full Text] [Related]  

  • 33. [Increase in the specific activity of killed influenza vaccines by using polyene antibiotics].
    Shneĭder MA; Shtil'bans EB; Paleĭ EI; Vil'ner LM; Tereshin IM
    Antibiotiki; 1981 Jul; 26(7):532-7. PubMed ID: 7271267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Virus-inhibiting properties of the carbonyl-conjugated pentaene roseofungin].
    Shneĭder MA; Shtil'bans EB; Rachkovskaia LA; Vetlugina LA; Nikitina ET
    Antibiotiki; 1984 May; 29(5):344-9. PubMed ID: 6331293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral resistance in influenza viruses--implications for management and pandemic response.
    Hayden FG
    N Engl J Med; 2006 Feb; 354(8):785-8. PubMed ID: 16495389
    [No Abstract]   [Full Text] [Related]  

  • 36. [Methodological aspects of studying chemical preparations in a model of experimental influenzal infection].
    Nikitina LE; Noskov FS; Fridman EA; Peradze TV
    Vopr Virusol; 1987; 32(5):579-82. PubMed ID: 3433716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human monoclonal ScFv specific to NS1 protein inhibits replication of influenza viruses across types and subtypes.
    Yodsheewan R; Maneewatch S; Srimanote P; Thueng-In K; Songserm T; Dong-Din-On F; Bangphoomi K; Sookrung N; Choowongkomon K; Chaicumpa W
    Antiviral Res; 2013 Oct; 100(1):226-37. PubMed ID: 23928258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Our experience treating deep mycoses with amphoglucamine].
    Moskovskaia MA
    Antibiotiki; 1981 Feb; 26(2):118-20. PubMed ID: 7212692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antivirals for the chemoprophylaxis and treatment of influenza.
    Van Voris LP; Newell PM
    Semin Respir Infect; 1992 Mar; 7(1):61-70. PubMed ID: 1609169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rimantadine for prevention and treatment of influenza.
    Med Lett Drugs Ther; 1993 Nov; 35(910):109-10. PubMed ID: 8232065
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.